A 2-h indirect enzyme-linked immunosorbent assay (ELISA) using homogenate antigens of Rhizopus arrhizus and Rhizomucor pusillus was developed and compared with the existing immunodiffusion (ID) test for zygomycosis, using homogenate antigens of R. arrhizus. Utilizing 1:400 as a minimally positive ELISA titer, 33 of 43 proven cases of zygomycosis were diagnosed. The sensitivity of the ELISA was 81%. The Serologic methods. Micro-ID tests with homogenate antigens were performed as previously described (3). Antisera were diffused for 3 h, and then optimally diluted antigens were added. The plates were incubated at 25°C for 72 h, after which they were examined for precipitins that formed bands of identity with those produced by selected rabbit reference antisera. The ELISA used was a modificationof a standard indirect enzyme immunoassay (6). Standard checkerboard titrations were performed to determine the optimal-dilutions of antigens, antisera, and conjugates. Immulon Il (Dynatech Laboratories, Inc., Alexandria, Va.) Pittsburgh, Pa.). Two hundred microliters of PBS-T-1.0% bovine serum albumin was added to each well. The plate was incubated at 27°C for 30 min and washed with PBS-T. Serum specimens were diluted 1:100 in PBS-T-0.1% bovine serum albumin. Serum from a patient with zygomycosis was included as a positive control with each plate. Pooled normal human sera were used as negative controls. The serum specimens were added to the plates in 300-,l1 volumes, and twofold dilutions were made. The plates were incubated for 30 min at 27°C in a water bath and then washed with PBS-T. Two hundred microliters of horseradish peroxidase-conjugated goat antihuman immunoglobulin G (heavy-and light-chain-specific; Hyclone Laboratories, Logan, Utah) diluted in PBS-Tbovine serum albumin was added to each well, and the plates were incubated at 27°C for 30 min in a water bath. The wells were washed with PBS-T.
Systemic zygomycosis is a frequently fatal opportunistic disease of severely immunocompromised or debilitated patients. Most diagnoses are based on histologie findings, and many are not achieved until autopsy. Development of a sensitive and specific immunologic test could provide a rapid and noninvasive diagnostic tool. Although immunodiffusion (ID) tests have been successfully used to detect antibodies in patients with active zygomycotic infections (1, 3, 5) , their sensitivity and specificity are far from optimal. Because the enzyme-linked immunosorbent assay (ELISA) is more sensitive than ID, we adapted this procedure to the diagnosis of zygomycosis. The present study is a comparative evaluation of the ELISA and ID tests for antibodies to pathogenic zygomycetes classified in the order Mucorales.
MATERIALS AND METHODS Antigen preparation. Homogenate antigens were prepared from Rhizopus arrhizus (B-3157) and Rhizomucor pusillus (B-1319) by the method of Jones and Kaufman (3) . Mycelial growth harvested from shaken Sabouraud dextrose broth cultures grown for 48 to 72 h at 37°C was disrupted in an MSK mechanical cell homogenizer (Braun) for 5 min.' The homogenized elements were decanted, and the beads were washed five times with phosphate-buffered saline (PBS), pH 7.2, containing 0.01% Merthiolate. The washings were combined with the homogenate and then centrifuged at 12,062 x g for 1 h. The supernatant was decanted and concentrated in an E-20 apparatus with a PM-10 filter (Amicon Corp., Lexington, Mass.). Each homogenate antigen was adjusted to yield 0.7 to 0.9 mg of protein per ml (2) and stored at -200C.
Serum specimens. Serum specimens were obtained from patients with'histologically or culturally proven cases of aspergillosis (n = 22), candidiasis (n -14), cryptococcosis (n = 2), pseudallescheriasis (n = 5), and zygomycosis (n = 46). Forty-three of the zygomycosis cases involved infections by members of the order Mucorales. Clinically, 22 rhinocerebral, 14 pulmonary, 4 0.003% H202 (Mallinckrodt, Inc., St. Louis, Mo.) containing 0.01% (wt/vol) ortho-phenylenediamine (Aldrich Chemical Co. Inc., Milwaukee, Wis.) was added, and the wells were incubated in the dark for 30 min at 24°C. The reactions were stopped by adding 50 ,ul of 8 N H2SO4. The A4., was measured on an ELISA reader (MR 600; Dynatech). Titers were determined as the net absorbance reading after subtraction of the corresponding dilution of the negative control. Any absorbance value greater than or equal to 0.200 was considered positive. The highest dilution that gave a positive result was considered the titer.
RESULTS
Minimal positive titer. Preliminary titrations with serum specimens from normal healthy individuals, diabetic patients, and patients with zygomycosis were performed to determine the best initial antiserum dilution. The studies indicated that all the control and zygomycosis serum specimens reacted at titers of 1:32 to 1:128. Accordingly, initial dilutions were begun at 1:100. To minimize false-positives, serum titers equal to or greater than 1:400 were considered minimally positive.
Sensitivity with human patient sera. Serum specimens from 43 patients who had histological or cultural proof of systemic or cutaneous zygomycosis were tested against the homogenate antigens of Rhizopus arrhizus and Rhizomucor pusillus. Serum specimens from 33 of the 43 patients (81%) yielded titers of 1:400 or greater to one or both of the antigens ( Table  1 ). The range of ELISA titers of sera positive for each antigen was 1:400 to 1:6,400. Of the 33 ELISA-positive zygomycosis patient specimens, only 18 (55%) were positive in the ID test. Diagnostic precipitins were detected in 21 of the 43 patients (66%). Of these 21, 18 were ELISA positive. Serum specimens from 22 of the patients were ID negative. The ID test and ELISA results were in agreement in only 25 of the 43 cases (58%).
The serological reactivities observed for the patients according to their clinical forms of zygomycosis are presented in Table 2 . The patients were categorized further on the basis of their predisposing illnesses or conditions. Of the 22 patients with the most prevalent form, rhinocerebral zygomycosis, 15 (68%) were positive in the ELISA with at least one of the antigens. The titers ranged from 1:400 to 1:6,400 for both antigens. Serum specimens from 13 of the 14 pulmonary cases gave positive antibody reactions. Twelve were positive with Rhizopus arrhizus, and thirteen were positive with Rhizomucor pusillus. Three of the four disseminated cases gave positive reactions to both antigens. Two of three patients with the cutaneous or gastrointestinal forms were also positive in the ELISA. Since patients with diabetes constitute the group most at risk for zygomycosis, it is noteworthy that zygomycete antibodies were detected in 19 reactions with the other three absorbed candidiasis patient serum specimens suggest that the ELISA reactions with the unabsorbed sera were due to cross-reacting Candida spp. antibodies. The two zygomycosis patient serum specimens showed titer declines after absorption, but both retained high levels of zygomycete antibodies. Because serum specimens from patients with candidiasis and aspergillosis showed cross-reactivity in the ELISA against the zygomycete antigens, tests were performed to determine whether any cross-reactivity would occur between eight randomly selected zygomycosis patient serum specimens and Candida albicans or Aspergillus sp. antigens in ID tests (Table 5) . Two of the serum specimens showed bands of identity when tested in the Candida ID test, and none reacted with four Aspergillus spp. antigens.
DISCUSSION
Preliminary studies with serum specimens from rabbits hyperimmunized with filtrate and homogenate antigens of Absidia corymbifera, Cunninghamella bertholletiae, Rhizopus arrhizus, and Rhizomucor pusillus indicated strong antigenic relationships among these fungi. They also revealed that Rhizopus arrhizus and Rhizomucor pusillus were the most sensitive antigens for detecting homologous and heterologous zygomycete (order Mucorales) antibodies. A 2-h indirect ELISA for zygomycete antibodies using homogenate antigens of both Rhizopus arrhizus and Rhizomucor pusillus was evaluated. By using 1:400 as a minimally positive titer, 33 of 43 proven systemic and cutaneous zygomycosis cases were diagnosed. The sensitivity of the ELISA was shown to be 81% (Tables 1, 2 (3) . The specificity of the ELISA was determined by testing 135 serum specimens from normal individuals, diabetics, and patients with a variety of different infections and illnesses. Of the 135 serum specimens, 11 reacted, to yield a specificity of 93% (Table 3 ). When the 3 entomophthoromycosis patient serum specimens were excluded, only 9 of the remaining 132 serum specimens were reactive in the ELISA against one or both zygomycete antigens, providing a 94% level of specificity (Table 6 ). Nonspecific reactivity was particularly evident with sera from the patients with nonzygomycotic infections, such as aspergillosis and candidiasis. Only 29 of the 132 control serum specimens were available to be tested by ID. Of these 29, 3 were positive, indicating a specificity of 91% for the ID test.
During this investigation, we examined the specificity and sensitivity of the ELISA, using a minimal positive titer of 1:200 rather than 1:400. Of the 132 nonzygomycotic serum specimens, 16 additional serum specimens from normal persons, diabetics, and patients with heterologous diseases gave positive results in the ELISA, thus decreasing the specificity from 94 to 84% (Table 6 ). Use of the 1:200 minimal positive titer, however, increased the sensitivity of the ELISA to 86% (36 of 43). In the final analysis, practicality was considered the principal criterion for setting a minimal titer, i.e., that the results be useful in the clinical context for which the assay was intended. Accordingly, results represented by a 1:400 rather than a 1:200 or greater titer more accurately indicated a diagnosis of zygomycosis, as reflected by a diagnostic predictive value of 78% and a specificity of 94% (Table 6 ). Significantly lower values were obtained with the 1:200 minimal titer. Until further improvements in the test can be achieved, the 1:400 minimal positive titer and the use of both antigens are recommended. A 1:200 titer is regarded as suspicious, with follow-up studies recommended.
It is noteworthy that all of the sera from patients infected with the heterologous zygomycetes Cunninghamella bertholletiae, Rhizopus microsporus var. microsporus and var. rhizopodiformis, and S. vasiformis reacted with at least one of the test antigens at titers ranging from 1:400 to 1:3,200. Thus, the test is capable of detecting antibodies in cases of systemic zygomycosis caused by species other than Rhizopus arrhizus and Rhizomucor pusillus (4). Minimal reactivity (1:400) occurred with sera from patients with basidiobolomycosis.
Absorption studies (Table 4) suggested that the nonspecific reactions with serum specimens from patients having other fungal infections, such as aspergillosis and candidiasis, could be due to concomitant infection with a zygomycete or by cross-reactivity with the zygomycete antigens (Table 4) . Although aspergillosis and candidiasis serum specimens cross-reacted in the zygomycosis test, the zygomycosis serum specimens showed no reactivity in the ID test for aspergillosis and minimal reactivity in the ID test for candidiasis (Table 5 ).
The 2-h assay proved to be practical and simple for obtaining reliable and reproducible results. The test is useful for detecting zygomycete antibodies, and the results are meaningful when interpreted with knowledge concerning the clinical state of the patient. ELISA provides advantages over the ID test, which requires serum to be concentrated and preincubated for 3 h before the addition of antigen. In addition, a 72-h incubation period is necessary before the ID test results can be read.
The ELISA is recommended as a screening tool in clinics in which diabetics, drug addicts, burn victims, and immunocompromised patients present symptoms of rhinocerebral, pulmonary, or disseminated infection. Obviously, additional studies are needed with purified antigens or monoclonal antibodies to improve the sensitivity and specificity of the ELISA described above.
